-
2
-
-
41549117102
-
Observational research, randomised trials, and two views of medical science
-
Vandenbroucke J. Observational research, randomised trials, and two views of medical science . PLOS Med 2008; 5: 339-43.
-
(2008)
PLOS Med
, vol.5
, pp. 339-343
-
-
Vandenbroucke, J.1
-
3
-
-
0034702175
-
Randomized, controlled trials, observational studies and the hierarchy of research designs
-
Concato J, Shah N, Horwitz RI. Randomized, controlled trials, observational studies and the hierarchy of research designs . N Engl J Med 2000; 342: 1887-92.
-
(2000)
N Engl J Med
, vol.342
, pp. 1887-1892
-
-
Concato, J.1
Shah, N.2
Horwitz, R.I.3
-
4
-
-
57849129354
-
De Testimonio. On the evidence for decisions about the use of therapeutic interventions
-
Rawlins, MD, De Testimonio. On the evidence for decisions about the use of therapeutic interventions . Clin Med 2008; 8: 579-88.
-
(2008)
Clin Med
, vol.8
, pp. 579-588
-
-
Rawlins, M.D.1
-
5
-
-
36549040492
-
In defense of pharmacoepidemiology - embracing the yin and yang of drug research
-
Avorn J. In defense of pharmacoepidemiology - embracing the yin and yang of drug research . N Engl J Med 2007; 357: 2219-21.
-
(2007)
N Engl J Med
, vol.357
, pp. 2219-2221
-
-
Avorn, J.1
-
6
-
-
47349129001
-
-
2nd edn . (Prepared by Outcome DEcIDE Center [Outcome Sciences, Inc. dba Outcome] under Contract No. HHSA29020050035I TO1.) AHRQ Publication No. 10 -EHC049. Rockville, MD: Agency for Healthcare Research and Quality
-
Gliklich RE, Dreyer NA, eds. Registries for Evaluating Patient Outcomes: A User ' s Guide, 2nd edn . (Prepared by Outcome DEcIDE Center [Outcome Sciences, Inc. dba Outcome] under Contract No. HHSA29020050035I TO1.) AHRQ Publication No. 10 -EHC049. Rockville, MD: Agency for Healthcare Research and Quality , 2010.
-
(2010)
eds. Registries for Evaluating Patient Outcomes: A User ' s Guide
-
-
Gliklich, R.E.1
Dreyer, N.A.2
-
7
-
-
44849096465
-
Implications for registry -based vaccine effectiveness studies from an evaluation of an immunization registry: A cross -sectional study
-
Mahon BE, Shea KM, Dougherty NN, Loughlin AM. Implications for registry -based vaccine effectiveness studies from an evaluation of an immunization registry: A cross -sectional study . BMC Public Health 2008; 8: 160.
-
(2008)
BMC Public Health
, vol.8
, pp. 160
-
-
Mahon, B.E.1
Shea, K.M.2
Dougherty, N.N.3
Loughlin, A.M.4
-
9
-
-
0033050539
-
. Immunization registries in the United States: implications for the practice of public health in a changing health care system
-
Wood D, Saarlas KN, Inkelas M, Matyas BT . Immunization registries in the United States: implications for the practice of public health in a changing health care system . Annu Rev Public Health 1999; 20: 231-55.
-
(1999)
Annu Rev Public Health
, vol.20
, pp. 231-255
-
-
Wood, D.1
Saarlas, K.N.2
Inkelas, M.3
Matyas, B.T.4
-
10
-
-
0036642395
-
A risk model derived from the National Registry of Myocardial Infarction 2 database for predicting mortality after coronary artery bypass grafting during acute myocardial infarction
-
Zaroff JG, diTommaso DG, Barron HV . A risk model derived from the National Registry of Myocardial Infarction 2 database for predicting mortality after coronary artery bypass grafting during acute myocardial infarction . Am J Cardiol 2002; 90: 1-4.
-
(2002)
Am J Cardiol
, vol.90
, pp. 1-4
-
-
Zaroff, J.G.1
diTommaso, D.G.2
Barron, H.V.3
-
11
-
-
84881382048
-
-
Cystic Fibrosis Foundation (accessed May)
-
Cystic Fibrosis Foundation . Patient Registry Report. www.cff.org/LivingWithCF/QualityImprovement/ PatientRegistryReport (accessed May, 2010).
-
(2010)
Patient Registry Report
-
-
-
12
-
-
77956988482
-
Effectiveness of antiviral treatment in human influenza H5N1 infections: analysis from a global patient registry
-
Adisasmito W, Chan PKS, Lee N, Oner AF , Gasimov V, Aghayev F, et al. Effectiveness of antiviral treatment in human influenza H5N1 infections: analysis from a global patient registry . J Infect Dis 2010; 202: 1154-60.
-
(2010)
J Infect Dis
, vol.202
, pp. 1154-1160
-
-
Adisasmito, W.1
Chan, P.K.S.2
Lee, N.3
Oner, A.F.4
Gasimov, V.5
Aghayev, F.6
-
13
-
-
84888742091
-
-
European Society for Paediatric Infectious Diseases, Nice, France, May
-
Oner AF , Bamgboye E, Gasimov V, Zaman M, Chan PKS, Lee N, et al. Avian Influenza Infections in Children: Symptoms and Treatment. European Society for Paediatric Infectious Diseases, Nice, France, May, 2010.
-
(2010)
Avian Influenza Infections in Children: Symptoms and Treatment
-
-
Oner, A.F.1
Bamgboye, E.2
Gasimov, V.3
Zaman, M.4
Chan, P.K.S.5
Lee, N.6
-
14
-
-
0015225140
-
Adenocarcinoma of the vagina: association of maternal stilbestrol therapy with tumor appearance in young women
-
Herbst AL, Ulfelder H, Poskanzer DC. Adenocarcinoma of the vagina: association of maternal stilbestrol therapy with tumor appearance in young women . N Engl J Med 1971; 284: 878-81.
-
(1971)
N Engl J Med
, vol.284
, pp. 878-881
-
-
Herbst, A.L.1
Ulfelder, H.2
Poskanzer, D.C.3
-
15
-
-
0015519148
-
Clear -cell adenocarcinomas of the genital tract in young females, Registry report
-
Herbst AL, Kurman RJ, Scully RE. Clear -cell adenocarcinomas of the genital tract in young females. Registry report . N Engl J Med 1972; 287: 1259-64.
-
(1972)
N Engl J Med
, vol.287
, pp. 1259-1264
-
-
Herbst, A.L.1
Kurman, R.J.2
Scully, R.E.3
-
16
-
-
0034626360
-
The Gaucher Registry: demographics and disease characteristics of 1698 patients with Gaucher disease
-
Charrow J, Andersson HC, Kaplan P, Kolodny EH, Mistry P, Pastores G, et al. The Gaucher Registry: demographics and disease characteristics of 1698 patients with Gaucher disease . Arch Intern Med 2000; 160: 2835-43.
-
(2000)
Arch Intern Med
, vol.160
, pp. 2835-2843
-
-
Charrow, J.1
Andersson, H.C.2
Kaplan, P.3
Kolodny, E.H.4
Mistry, P.5
Pastores, G.6
-
17
-
-
62449324950
-
Follicular lymphoma in the United States: First report of the national lymphocare study
-
Friedberg JW , Taylor MD, Cerhan JR, Flowers CR, Dillon H, Farber CM, et al. Follicular lymphoma in the United States: First report of the national lymphocare study . J Clin Oncol 2009; 27: 1202-8.
-
(2009)
J Clin Oncol
, vol.27
, pp. 1202-1208
-
-
Friedberg, J.W.1
Taylor, M.D.2
Cerhan, J.R.3
Flowers, C.R.4
Dillon, H.5
Farber, C.M.6
-
18
-
-
60649117968
-
Stenting and angioplasty with protecting in patients at high -risk for endarterectomy: SAPPHIRE worldwide registry first 2,001 patients
-
Massop D, Dave R, Metzger C, Bachinsky W, Solis M, Shah R, et al. Stenting and angioplasty with protecting in patients at high -risk for endarterectomy: SAPPHIRE worldwide registry first 2,001 patients . Catheter Cardiovasc Interv 2009; 73: 129-36.
-
(2009)
Catheter Cardiovasc Interv
, vol.73
, pp. 129-136
-
-
Massop, D.1
Dave, R.2
Metzger, C.3
Bachinsky, W.4
Solis, M.5
Shah, R.6
-
19
-
-
75249099806
-
Are quality improvements associated with the Get With the Guidelines -Coronary Artery Disease (GWTG -CAD) program sustained over time? A longitudinal comparison of GWTG -CAD hospitals versus non -GWTG-CAD hospitals
-
Xian Y, Pan W, Peterson ED, Heidenreich PA , Cannon CP , Hernandez AF , et al. Are quality improvements associated with the Get With the Guidelines -Coronary Artery Disease (GWTG -CAD) program sustained over time? A longitudinal comparison of GWTG -CAD hospitals versus non -GWTG-CAD hospitals . Am Heart J 2010; 159: 207-14.
-
(2010)
Am Heart J
, vol.159
, pp. 207-214
-
-
Xian, Y.1
Pan, W.2
Peterson, E.D.3
Heidenreich, P.A.4
Cannon, C.P.5
Hernandez, A.F.6
-
20
-
-
84888681739
-
Illinois Comprehensive Automated Immunization Registry Exchange (I - CARE) Fact Sheet
-
Illinois Department of Public Health (accessed Aug.)
-
Illinois Department of Public Health . Illinois Comprehensive Automated Immunization Registry Exchange (I - CARE) Fact Sheet. http://www.idph. state.il.us/health/vaccine/icarefs.html (accessed Aug., 2010).
-
(2010)
-
-
-
21
-
-
39749089389
-
-
ISPE. Guidelines for good pharmacoepidemiology practices (GPP)
-
ISPE. Guidelines for good pharmacoepidemiology practices (GPP) . Pharmacoepidemiol Drug Saf 2008; 17: 200-8.
-
(2008)
Pharmacoepidemiol Drug Saf
, vol.17
, pp. 200-208
-
-
-
23
-
-
35848948166
-
The strengthening the report ing of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies
-
Von Elm E, Altman DG, Egger M, Pocock SJ, Gotzche PC, Vandenbroucke JP . The strengthening the report ing of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies . Ann Intern Med 2007; 147: 573-7.
-
(2007)
Ann Intern Med
, vol.147
, pp. 573-577
-
-
Von Elm, E.1
Altman, D.G.2
Egger, M.3
Pocock, S.J.4
Gotzche, P.C.5
Vandenbroucke, J.P.6
-
24
-
-
77954108319
-
on behalf of the GRACE Initiative, GRACE principles: recognizing high -quality observational studies of comparative effectiveness
-
Dreyer NA, Schneeweiss S, McNeil B, Berger ML, Walker A, et al, on behalf of the GRACE Initiative. GRACE principles: recognizing high -quality observational studies of comparative effectiveness . Am J Manag Care 2010; 16: 467-71.
-
(2010)
Am J Manag Care
, vol.16
, pp. 467-471
-
-
Dreyer, N.A.1
Schneeweiss, S.2
McNeil, B.3
Berger, M.L.4
Walker, A.5
-
25
-
-
0032557175
-
Variation in carotid endarterectomy mortality in the medicare population: trial hospitals, volume, and patient characteristics
-
Wennberg DE, Lucas FL, Birkmeyer JD, Bredenberg CE, Fisher ES. Variation in carotid endarterectomy mortality in the medicare population: trial hospitals, volume, and patient characteristics . JAMA 1998; 279: 1278-81.
-
(1998)
JAMA
, vol.279
, pp. 1278-1281
-
-
Wennberg, D.E.1
Lucas, F.L.2
Birkmeyer, J.D.3
Bredenberg, C.E.4
Fisher, E.S.5
-
26
-
-
84888765519
-
-
American Society of Clinical Oncology, Chicago, June
-
Kaufman PA , Dreyer NA, Mayer M, Sloan JA, Chung CY , Sing A, et al. Capturing breast cancer patients experience beyond disease progression: implementation of a patient - reported outcome (PRO) substudy in the VIRGO metastatic breast cancer observational cohort study. American Society of Clinical Oncology, Chicago, June, 2010.
-
(2010)
Capturing breast cancer patients experience beyond disease progression: implementation of a patient - reported outcome (PRO) substudy in the VIRGO metastatic breast cancer observational cohort study
-
-
Kaufman, P.A.1
Dreyer, N.A.2
Mayer, M.3
Sloan, J.A.4
Chung, C.Y.5
Sing, A.6
-
27
-
-
84888753389
-
-
National Institute of Arthritis and Musculoskeletal and Skin Diseases, US Department of Health and Human Services (accessed May)
-
National Institute of Arthritis and Musculoskeletal and Skin Diseases, US Department of Health and Human Services . Patient Research Registries. http:// www.niams.nih.gov/Funding/Funded_Research/ registries.asp (accessed May, 2010).
-
(2010)
Patient Research Registries
-
-
-
28
-
-
84888719266
-
Surveillance, Epidemiology, and End Results
-
National Cancer Institute (accessed May)
-
National Cancer Institute . Surveillance, Epidemiology, and End Results. Overview of the SEER Program. http:// seer.cancer.gov/about/ (accessed May, 2010).
-
(2010)
Overview of the SEER Program
-
-
-
29
-
-
0022481337
-
Oral contraceptive use and risk of breast cancer
-
Cancer and Steroid Hormone Study of the Centers for Disease Control and the National Institute of Child Health and Human Development
-
Cancer and Steroid Hormone Study of the Centers for Disease Control and the National Institute of Child Health and Human Development . Oral contraceptive use and risk of breast cancer . N Engl J Med 1986; 315: 405-11.
-
(1986)
N Engl J Med
, vol.315
, pp. 405-411
-
-
-
30
-
-
0020676322
-
Oral contraceptive use and the risk of ovarian cancer
-
Anon
-
Anon. Oral contraceptive use and the risk of ovarian cancer . JAMA 1983; 249: 1596-9.
-
(1983)
JAMA
, vol.249
, pp. 1596-1599
-
-
-
31
-
-
0020691964
-
Oral contraceptive use and the risk of endometrial cancer
-
Anon
-
Anon. Oral contraceptive use and the risk of endometrial cancer . JAMA 1983; 249: 1600-4.
-
(1983)
JAMA
, vol.249
, pp. 1600-1604
-
-
-
33
-
-
39249084652
-
Demographic, clinical, and treatment trends among women diagnosed with vulvar cancer in the United States
-
Stroup AM, Harlan LC, Trimble EL. Demographic, clinical, and treatment trends among women diagnosed with vulvar cancer in the United States . Gynecol Oncol 2008; 108: 577-83.
-
(2008)
Gynecol Oncol
, vol.108
, pp. 577-583
-
-
Stroup, A.M.1
Harlan, L.C.2
Trimble, E.L.3
-
34
-
-
39049180984
-
Dissemination of adjuvant multiagent chemotherapy and tamoxifen for breast cancer in the United States using estrogen receptor information: 1975 -1999
-
Mariotto AB, Feuer EJ, Harlan LC, Abrams J. Dissemination of adjuvant multiagent chemotherapy and tamoxifen for breast cancer in the United States using estrogen receptor information: 1975 -1999. J Natl Cancer Inst Monogr 2006; 36: 7-15.
-
(2006)
J Natl Cancer Inst Monogr
, vol.36
, pp. 7-15
-
-
Mariotto, A.B.1
Feuer, E.J.2
Harlan, L.C.3
Abrams, J.4
-
35
-
-
84888757544
-
Surveillance, Epidemiology, and End Results Program
-
National Cancer Institute (accessed May)
-
National Cancer Institute . Surveillance, Epidemiology, and End Results Program. SEER - Medicare Linked Database. http://seer.cancer.gov/about/seermedicare. html (accessed May, 2010).
-
(2010)
SEER - Medicare Linked Database
-
-
-
36
-
-
68049125885
-
Etiology of delays in the initiation of adjuvant chemotherapy and their impact on outcomes for Stage II and III rectal cancer
-
discussion 1064
-
Cheung WY , Neville BA, Earle CC. Etiology of delays in the initiation of adjuvant chemotherapy and their impact on outcomes for Stage II and III rectal cancer . Dis Colon Rectum 2009; 52: 1054-63; discussion 1064.
-
(2009)
Dis Colon Rectum
, vol.52
, pp. 1054-1063
-
-
Cheung, W.Y.1
Neville, B.A.2
Earle, C.C.3
-
37
-
-
69249144492
-
Influence of private practice setting and physician characteristics on the use of breast cancer adjuvant chemotherapy for elderly women
-
Hershman DL, Buono D, McBride RB, Tsai WY , Neugut AI. Influence of private practice setting and physician characteristics on the use of breast cancer adjuvant chemotherapy for elderly women . Cancer 2009; 115: 3848-57.
-
(2009)
Cancer
, vol.115
, pp. 3848-3857
-
-
Hershman, D.L.1
Buono, D.2
McBride, R.B.3
Tsai, W.Y.4
Neugut, A.I.5
-
38
-
-
69849097151
-
Hospital factors and racial disparities in mortality after surgery for breast and colon cancer
-
Breslin TM, Morris AM, Gu N, Wong SL, Finlayson EV , Banerjee M, et al. Hospital factors and racial disparities in mortality after surgery for breast and colon cancer . J Clin Oncol 2009; 27: 3945-50.
-
(2009)
J Clin Oncol
, vol.27
, pp. 3945-3950
-
-
Breslin, T.M.1
Morris, A.M.2
Gu, N.3
Wong, S.L.4
Finlayson, E.V.5
Banerjee, M.6
-
39
-
-
77950595853
-
Differences in melanoma outcomes among Hispanic Medicare enrollees
-
Rouhani P, Arheart KL, Kirsner RS. Differences in melanoma outcomes among Hispanic Medicare enrollees. J Am Acad Dermatol 2010; 62: 768-76.
-
(2010)
J Am Acad Dermatol
, vol.62
, pp. 768-776
-
-
Rouhani, P.1
Arheart, K.L.2
Kirsner, R.S.3
-
40
-
-
84888691251
-
-
US Hereditary Angioedema Association (accessed June)
-
US Hereditary Angioedema Association . US HAE Scientific Registry: Patient Driven Research for a Cure. http://www.haea.org/get -involved/us-haea-scientific -registry/ (accessed June 2011).
-
(2011)
US HAE Scientific Registry: Patient Driven Research for a Cure
-
-
-
41
-
-
68949121335
-
Registries for robust evidence
-
Dreyer NA, Garner S. Registries for robust evidence . JAMA 2009; 302: 790-1.
-
(2009)
JAMA
, vol.302
, pp. 790-791
-
-
Dreyer, N.A.1
Garner, S.2
-
42
-
-
65249143891
-
Clinical effectiveness of coronary stents in the elderly: results from 262, 700 Medicare patients in ACC -NCDR
-
Douglas PS, Brennan JM, Anstrom KJ, Sedrakyan A, Eisenstein EL, et al. Clinical effectiveness of coronary stents in the elderly: results from 262,700 Medicare patients in ACC -NCDR. J Am Coll Cardiol 2009; 53: 1629-41.
-
(2009)
J Am Coll Cardiol
, vol.53
, pp. 1629-1641
-
-
Douglas, P.S.1
Brennan, J.M.2
Anstrom, K.J.3
Sedrakyan, A.4
Eisenstein, E.L.5
-
43
-
-
84888667035
-
Food and Drug Administration, United States Department of Health and Human Services
-
Center for Biologics Evaluation and Research (CBER) (accessed May)
-
Center for Biologics Evaluation and Research (CBER) , Food and Drug Administration, United States Department of Health and Human Services. Guidance for Industry: Gene Therapy Clinical Trials - Observing Subjects for Delayed Adverse Events. http://www.fda.gov/BiologicsBlood Vaccines/GuidanceComplianceRegulatoryIn formation/ Guidances/CellularandGeneTherapy/ucm072957.htm (accessed May, 2010).
-
(2010)
Guidance for Industry: Gene Therapy Clinical Trials - Observing Subjects for Delayed Adverse Events
-
-
-
44
-
-
84888731146
-
European Medicines Agency. Guideline on Safety and Efficacy Follow - Up - Risk Management of Advanced Therapy Medicinal Products
-
Committee for Medicinal Products for Human Use (CHMP), Doc. Ref. EMEA/149995/2008
-
Committee for Medicinal Products for Human Use (CHMP). Guideline on Safety and Efficacy Follow - Up - Risk Management of Advanced Therapy Medicinal Products, Doc. Ref. EMEA/149995/2008 . European Medicines Agency, 2008.
-
(2008)
-
-
-
45
-
-
84888679079
-
Registries rising: FDA looking at TNF inhibitors; AHRQ updates standards
-
Hobbs MN. Registries rising: FDA looking at TNF inhibitors; AHRQ updates standards . Pink Sheet 2009; 71: 8-9.
-
(2009)
Pink Sheet
, vol.71
, pp. 8-9
-
-
Hobbs, M.N.1
-
46
-
-
77953643565
-
Framework for evidence evaluation and methodological issues in implantable device studies
-
Sedrakyan A, Marinac-Dabic D, Normand SL, Mushlin A, Gross T. Framework for evidence evaluation and methodological issues in implantable device studies. Med Care 2010; 48 (6 Suppl): S121-8.
-
(2010)
Med Care
, vol.48
, Issue.6 SUPPL.
-
-
Sedrakyan, A.1
Marinac-Dabic, D.2
Normand, S.L.3
Mushlin, A.4
Gross, T.5
-
47
-
-
84888652015
-
Food and Drug Administration, United States Department of Health and Human Services (accessed April)
-
Center for Drug Evaluation and Research (CDER) and Center for Biologics Evaluation and Research (CBER)
-
Center for Drug Evaluation and Research (CDER) and Center for Biologics Evaluation and Research (CBER). Guidance for Industry: Establishing Pregnancy Exposure Registries. Food and Drug Administration, United States Department of Health and Human Services. http://www.fda.gov/downloads/ Drugs/GuidanceComplianceRegulatoryInformation/ Guidances/UCM071639.pdf(accessed April, 2010).
-
(2010)
Guidance for Industry: Establishing Pregnancy Exposure Registries
-
-
-
48
-
-
84888717067
-
Guideline on the Exposure to Medicinal Products During Pregnancy: Need for Post - Authorisation Data
-
Committee for Medicinal Products for Human Use (CHMP), EMEA/CHMP/313666/2005. European Medicines Agency, Adopted November 2005 (accessed April)
-
Committee for Medicinal Products for Human Use (CHMP). Guideline on the Exposure to Medicinal Products During Pregnancy: Need for Post - Authorisation Data, EMEA/CHMP/313666/2005. European Medicines Agency, Adopted November 2005. http://www. ema.europa.eu/pdfs/human/phvwp/31366605en.pdf(accessed April, 2010).
-
(2010)
-
-
-
50
-
-
71549141310
-
Population-based study of antiepileptic drug exposure in utero - influence on head circumference in newborns
-
Almgren M, Källén B, Lavebratt C. Population-based study of antiepileptic drug exposure in utero - influence on head circumference in newborns . Seizure 2009; 18: 672-5.
-
(2009)
Seizure
, vol.18
, pp. 672-675
-
-
Almgren, M.1
Källén, B.2
Lavebratt, C.3
-
51
-
-
45849126466
-
Maternal use of thyroid hormones in pregnancy and neonatal outcome
-
Wikner BN, Sparre LS, Stiller CO, Källén B, Asker C. Maternal use of thyroid hormones in pregnancy and neonatal outcome . Acta Obstet Gynecol Scand 2008; 87: 617-27.
-
(2008)
Acta Obstet Gynecol Scand
, vol.87
, pp. 617-627
-
-
Wikner, B.N.1
Sparre, L.S.2
Stiller, C.O.3
Källén, B.4
Asker, C.5
-
52
-
-
51449100218
-
Maternal use of antipsychotics in early pregnancy and delivery outcome
-
Reis M, Källén B. Maternal use of antipsychotics in early pregnancy and delivery outcome . J Clin Psychopharmacol 2008; 28: 279-88.
-
(2008)
J Clin Psychopharmacol
, vol.28
, pp. 279-288
-
-
Reis, M.1
Källén, B.2
-
53
-
-
41749113848
-
Maternal use of loperamide in early pregnancy and delivery outcome
-
Källén B, Nilsson E, Otterblad Olausson P. Maternal use of loperamide in early pregnancy and delivery outcome. Acta Paediatr 2008; 97: 541-5.
-
(2008)
Acta Paediatr
, vol.97
, pp. 541-545
-
-
Källén, B.1
Nilsson, E.2
Otterblad Olausson, P.3
-
54
-
-
33947142396
-
Use of anti -asthmatic drugs during pregnancy. 1. Maternal characteristics, pregnancy and delivery complications
-
Källén B, Otterblad Olausson P. Use of anti -asthmatic drugs during pregnancy. 1. Maternal characteristics, pregnancy and delivery complications . Eur J Clin Pharmacol 2007; 63: 363-73.
-
(2007)
Eur J Clin Pharmacol
, vol.63
, pp. 363-373
-
-
Källén, B.1
Otterblad Olausson, P.2
-
56
-
-
0029945501
-
Maternal and perinatal risk factors for childhood brain tumors (Sweden)
-
Linet MS, Gridley G, Cnattingius S, Nicholson HS, Martinsson U, Glimelius B, et al. Maternal and perinatal risk factors for childhood brain tumors (Sweden). Cancer Causes Control 1996; 7: 437-48.
-
(1996)
Cancer Causes Control
, vol.7
, pp. 437-448
-
-
Linet, M.S.1
Gridley, G.2
Cnattingius, S.3
Nicholson, H.S.4
Martinsson, U.5
Glimelius, B.6
-
57
-
-
4544264072
-
Assessing teratogenicity of antiretroviral drugs: monitoring and analysis plan of the Antiretroviral Pregnancy Registry
-
Covington DL, Tilson H, Elder J, Doi P. Assessing teratogenicity of antiretroviral drugs: monitoring and analysis plan of the Antiretroviral Pregnancy Registry . Pharmacoepidemiol Drug Saf 2004; 13: 537-45.
-
(2004)
Pharmacoepidemiol Drug Saf
, vol.13
, pp. 537-545
-
-
Covington, D.L.1
Tilson, H.2
Elder, J.3
Doi, P.4
-
58
-
-
84888714928
-
Antiretroviral Pregnancy Registry International Interim Report for 1 January 1989 through 31 July 2009
-
Antiretroviral Pregnancy Registry Steering Committee, 2009. Wilmington, NC: Registry Coordinating Center (accessed June)
-
Antiretroviral Pregnancy Registry Steering Committee . Antiretroviral Pregnancy Registry International Interim Report for 1 January 1989 through 31 July 2009. Wilmington, NC: Registry Coordinating Center , 2009. http://www.APRegistry.com (accessed June 2011).
-
(2011)
-
-
-
59
-
-
4644291083
-
Assessing the risk of birth defects associated with antiretroviral exposure during pregnancy
-
Watts DH, Covington DL, Beckerman K, Garcia P, Scheuerle A, Dominguez K, et al. Assessing the risk of birth defects associated with antiretroviral exposure during pregnancy . Am J Obstet Gynecol 2004; 191: 985-92.
-
(2004)
Am J Obstet Gynecol
, vol.191
, pp. 985-992
-
-
Watts, D.H.1
Covington, D.L.2
Beckerman, K.3
Garcia, P.4
Scheuerle, A.5
Dominguez, K.6
-
60
-
-
84888729205
-
Public Workshop on Developing a Consolidated Pediatric Rheumatology Observational Registry
-
Center for Drug Evaluation and Research (CDER) (accessed May), May 12 - 13, 2009
-
Center for Drug Evaluation and Research (CDER) . Public Workshop on Developing a Consolidated Pediatric Rheumatology Observational Registry, May 12 - 13, 2009. http://www.fda.gov/downloads/Drugs/NewsEvents/ UCM171762.pdf(accessed May, 2010).
-
(2010)
-
-
-
61
-
-
84891367636
-
Postmarket Requirements and Commitments
-
Food and Drug Administration, United States Department of Health and Human Services (accessed May)
-
Food and Drug Administration, United States Department of Health and Human Services . Postmarket Requirements and Commitments. http://www.accessdata. fda.gov/scripts/cder/pmc/index.cfm (accessed May, 2010).
-
(2010)
-
-
-
62
-
-
65249090204
-
Association of physician certification and outcomes among patients receiving an implantable cardioverter -defibrillator
-
Curtis JP , Luebbart JJ, Wang Y, Rathmore SS, Chen J, Heidenreich PA , et al. Association of physician certification and outcomes among patients receiving an implantable cardioverter -defibrillator . JAMA 2009; 301: 1661-70.
-
(2009)
JAMA
, vol.301
, pp. 1661-1670
-
-
Curtis, J.P.1
Luebbart, J.J.2
Wang, Y.3
Rathmore, S.S.4
Chen, J.5
Heidenreich, P.A.6
-
63
-
-
0142151034
-
Using "get with the guidelines " to improve cardiovascular secondary prevention
-
LaBresh KA, Gliklich R, Liljestrand J, Peto R, Ellrodt AG. Using "get with the guidelines " to improve cardiovascular secondary prevention . Jt Comm J Qual Saf 2003; 29: 539-50.
-
(2003)
Jt Comm J Qual Saf
, vol.29
, pp. 539-550
-
-
LaBresh, K.A.1
Gliklich, R.2
Liljestrand, J.3
Peto, R.4
Ellrodt, A.G.5
-
64
-
-
43749121858
-
Impact of positron emission tomography/computed tomography and positron emission tomography (PET) alone on expected management of patients with cancer: initial results from the National Oncologic PET registry
-
Hillner BE, Siegel BA, Liu D, Shields AF , Gareen IF , Hanna L, et al. Impact of positron emission tomography/computed tomography and positron emission tomography (PET) alone on expected management of patients with cancer: initial results from the National Oncologic PET registry . J Clin Onc 2008; 26: 5316-19.
-
(2008)
J Clin Onc
, vol.26
, pp. 5316-5319
-
-
Hillner, B.E.1
Siegel, B.A.2
Liu, D.3
Shields, A.F.4
Gareen, I.F.5
Hanna, L.6
-
65
-
-
77953638697
-
Acting on comparative effectiveness research in COPD
-
Krishnan JA, Mularski RA. Acting on comparative effectiveness research in COPD . JAMA 2010; 303: 2409-10.
-
(2010)
JAMA
, vol.303
, pp. 2409-2410
-
-
Krishnan, J.A.1
Mularski, R.A.2
-
66
-
-
79951684079
-
Why observational studies should be among the tools used in comparative effectiveness research
-
Dreyer NA, Tunis SR, Berger M, Ollendorf D, Mattox PW , Gliklich RE. Why observational studies should be among the tools used in comparative effectiveness research. Health Affairs 2010; 29: 1818-25.
-
(2010)
Health Affairs
, vol.29
, pp. 1818-1825
-
-
Dreyer, N.A.1
Tunis, S.R.2
Berger, M.3
Ollendorf, D.4
Mattox, P.W.5
Gliklich, R.E.6
-
67
-
-
84888689447
-
FDA ' s Sentinel Initiative: Transforming How we Monitor the Safety of FDA - related Products
-
Food and Drug Administration, United States Department of Health and Human Services (accessed May)
-
Food and Drug Administration, United States Department of Health and Human Services . FDA ' s Sentinel Initiative: Transforming How we Monitor the Safety of FDA - related Products. http://www.fda.gov/ Safety/FDAsSentinelInitiative/default.htm (accessed May, 2010).
-
(2010)
-
-
-
68
-
-
68849085448
-
The new sentinel network - improving the evidence of medical -product safety
-
Platt R,Wilson M, Chan KA, Benner JS, Marchibroda J, McClellan M. The new sentinel network - improving the evidence of medical -product safety . N Engl J Med 2009; 361: 645-7.
-
(2009)
N Engl J Med
, vol.361
, pp. 645-647
-
-
Platt, R.1
Wilson, M.2
Chan, K.A.3
Benner, J.S.4
Marchibroda, J.5
McClellan, M.6
-
69
-
-
77954111739
-
100 Initial Priority Topics for Comparative Effectiveness Research
-
Institute of Medicine (accessed May)
-
Institute of Medicine . 100 Initial Priority Topics for Comparative Effectiveness Research. http://www. iom.edu/~/media/Files/Report%20Files/2009/ ComparativeEffectivenessResearchPriorities/Stand% 20Alone%20List%20of%20100%20CER%20 Priorities%20-%20for%20web.ashx (accessed May, 2010).
-
(2010)
-
-
-
70
-
-
84888737730
-
-
Genzyme (accessed June)
-
Genzyme. Pompe Registry . https://www.lsdregistry. net/pomperegistry (accessed June, 2010).
-
(2010)
Pompe Registry
-
-
-
71
-
-
84888714910
-
-
European Medicines Agency (accessed May)
-
European Medicines Agency . PROTECT . http:// www.imi -protect.eu (accessed May, 2010).
-
(2010)
PROTECT
-
-
-
72
-
-
13544261627
-
A brief conceptual tutorial of multilevel analysis in social epidemiology: linking the statistical concept of clustering to the idea of contextual phenomenon
-
Merlo J, Chaix B, Yang M, Lynch J, Rastam L. A brief conceptual tutorial of multilevel analysis in social epidemiology: linking the statistical concept of clustering to the idea of contextual phenomenon . J Epidemiol Comm Health 2005; 59: 443-9.
-
(2005)
J Epidemiol Comm Health
, vol.59
, pp. 443-449
-
-
Merlo, J.1
Chaix, B.2
Yang, M.3
Lynch, J.4
Rastam, L.5
-
73
-
-
0033929727
-
Multilevel analysis in public health research
-
Diez-Roux AV. Multilevel analysis in public health research. Annu Rev Public Health 2000; 21: 171-92.
-
(2000)
Annu Rev Public Health
, vol.21
, pp. 171-192
-
-
Diez-Roux, A.V.1
-
75
-
-
77953478206
-
Actionable indicators for short and long term outcomes in rectal cancer
-
Gort M, Otter R, Plukker JTM, Broekhuis M, Klazinga NS. Actionable indicators for short and long term outcomes in rectal cancer . Eur J Cancer 2010; 46: 1808-14.
-
(2010)
Eur J Cancer
, vol.46
, pp. 1808-1814
-
-
Gort, M.1
Otter, R.2
Plukker, J.T.M.3
Broekhuis, M.4
Klazinga, N.S.5
-
76
-
-
84888674002
-
Pfizer seeks ways to ease adverse events reporting digitally
-
March 30 (accessed May), 2010
-
Arnold M. Pfizer seeks ways to ease adverse events reporting digitally . Medical Marketing and Media, March 30, 2010 http://www.mmm -online.com/pfizer -seeksways-to-ease-adverse-events-reporting-digitally/ article/166947/ (accessed May, 2010).
-
(2010)
Medical Marketing and Media
-
-
Arnold, M.1
|